We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK icon
Splunk Inc
SPLK
+$446M
3
HES icon
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X icon
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
REPL icon
276
Replimune Group
REPL
$1.26B
$843K 0.03%
+100,000
New +$1.16M
2023 Q4
0 quarters
NET icon
277
Cloudflare
NET
$129B
$833K 0.03%
10,000
-35,000
-78% -$2.45M
2023 Q3
1 quarter
SVRA icon
278
Savara
SVRA
$1.01B
$831K 0.03%
176,886
-203,466
-53% -$780K
2022 Q2
6 quarters
BPMC icon
279
DELISTED
Blueprint Medicines
BPMC
$830K 0.03%
9,000
-39,984
-82% -$2.59M
2022 Q4
4 quarters
CRC icon
280
California Resources
CRC
$4.7B
$827K 0.03%
15,119
-1,529
-9% -$80.4K
2020 Q4
12 quarters
PRCT icon
281
Procept Biorobotics
PRCT
$1.05B
$826K 0.03%
19,717
-15,399
-44% -$524K
2022 Q4
4 quarters
FRSH icon
282
Freshworks
FRSH
$3.63B
$822K 0.03%
+35,000
New +$693K
2023 Q4
0 quarters
ADPT icon
283
Adaptive Biotechnologies
ADPT
$4.23B
$812K 0.03%
165,745
-35,595
-18% -$162K
2022 Q1
7 quarters
AURA icon
284
Aura Biosciences
AURA
$678M
$797K 0.03%
90,000
+46,000
+105% +$390K
2023 Q2
2 quarters
BDX icon
285
Becton Dickinson
BDX
$50.1B
$787K 0.02%
3,227
-10,044
-76% -$2.48M
2022 Q4
4 quarters
ADBE icon
286
Adobe
ADBE
$94.3B
$766K 0.02%
1,284
– –
2023 Q1
3 quarters
DXCM icon
287
DexCom
DXCM
$31.7B
$766K 0.02%
6,172
-18,828
-75% -$1.92M
2023 Q3
1 quarter
DYN icon
288
Dyne Therapeutics
DYN
$3.11B
$762K 0.02%
57,330
-53,422
-48% -$522K
2022 Q1
7 quarters
LBPH icon
289
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$743K 0.02%
123,206
-139,059
-53% -$693K
2023 Q1
3 quarters
DNLI icon
290
Denali Therapeutics
DNLI
$3.11B
$740K 0.02%
34,464
-24,488
-42% -$485K
2023 Q2
2 quarters
UDR icon
291
UDR
UDR
$11B
$737K 0.02%
19,236
-56,206
-75% -$1.96M
2023 Q3
1 quarter
SKIL icon
292
Skillsoft
SKIL
$55.6M
$733K 0.02%
+41,681
New +$729K
2023 Q4
0 quarters
MTH icon
293
Meritage Homes
MTH
$3.83B
$731K 0.02%
+8,390
New +$578K
2023 Q4
0 quarters
FCPT icon
294
Four Corners Property Trust
FCPT
$2.34B
$730K 0.02%
28,844
-14,416
-33% -$330K
2023 Q3
1 quarter
ZTO icon
295
ZTO Express
ZTO
$15.1B
$716K 0.02%
33,650
+11,160
+50% +$253K
2021 Q2
10 quarters
THRD icon
296
DELISTED
Third Harmonic Bio
THRD
$710K 0.02%
64,704
-60,296
-48% -$478K
2023 Q3
1 quarter
NKTR icon
297
Nektar Therapeutics
NKTR
$1.41B
$707K 0.02%
83,383
-8,367
-9% -$63.4K
2023 Q3
1 quarter
SPKLU
298
DELISTED
Spark I Acquisition Corp Unit
SPKLU
$702K 0.02%
+68,991
New +$700K
2023 Q4
0 quarters
CPT icon
299
Camden Property Trust
CPT
$11.3B
$697K 0.02%
7,023
-18,909
-73% -$1.75M
2022 Q2
6 quarters
KPTI icon
300
Karyopharm Therapeutics
KPTI
$13.7M
$694K 0.02%
53,488
-4,959
-8% -$66.8K
2022 Q1
7 quarters
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.